-
1.
公开(公告)号:US09556138B2
公开(公告)日:2017-01-31
申请号:US14384599
申请日:2013-03-12
Applicant: PIRAMAL ENTERPRISES LIMITED
Inventor: Somesh Sharma , Ashish Suthar , Kavita Salkar , Sandip Kedar
CPC classification number: C07D311/16 , A61K8/498 , A61K8/97 , A61K9/0014 , A61K31/37 , A61K36/73 , A61Q19/008
Abstract: The present disclosure relates to an anti-acne formulation comprising at least one active ingredient selected from the group consisting of coumarin based compounds of Formula I and Formula II; or pharmaceutically acceptable salts, polymorphs and derivatives thereof, and at least one pharmaceutically acceptable excipient. The present disclosure also relates to its application for preventing/curing/treating various acne conditions.
Abstract translation: 本公开内容涉及包含至少一种选自由式I和式II的基于香豆素的化合物组成的组的活性成分的抗痤疮制剂; 或其药学上可接受的盐,多晶型物及其衍生物,和至少一种药学上可接受的赋形剂。 本公开还涉及其用于预防/治疗/治疗各种痤疮病症的应用。
-
2.
公开(公告)号:US20150011619A1
公开(公告)日:2015-01-08
申请号:US14384599
申请日:2013-03-12
Applicant: PIRAMAL ENTERPRISES LIMITED
Inventor: Somesh Sharma , Ashish Suthar , Kavita Salkar , Sandip Kedar
IPC: C07D311/16
CPC classification number: C07D311/16 , A61K8/498 , A61K8/97 , A61K9/0014 , A61K31/37 , A61K36/73 , A61Q19/008
Abstract: The present disclosure relates to an anti-acne formulation comprising at least one active ingredient selected from the group consisting of coumarin based compounds of Formula I and Formula II; or pharmaceutically acceptable salts, polymorphs and derivatives thereof, and at least one pharmaceutically acceptable excipient. The present disclosure also relates to its application for preventing/curing/treating various acne conditions.
Abstract translation: 本公开内容涉及包含至少一种选自由式I和式II的基于香豆素的化合物组成的组的活性成分的抗痤疮制剂; 或其药学上可接受的盐,多晶型物及其衍生物,和至少一种药学上可接受的赋形剂。 本公开还涉及其用于预防/治疗/治疗各种痤疮病症的应用。
-